title: Cardiovascular effects of xenon and nitrous oxide in patients during fentanyl-midazolam anaesthesia.
abstract: Xenon anaesthesia appears to have minimal haemodynamic effects. The purpose of this randomised prospective study was to compare the cardiovascular effects of xenon and nitrous oxide in patients with known ischaemic heart disease. In 20 patients who were due to undergo coronary artery bypass graft surgery, 30 min following induction of anaesthesia with fentanyl 30 microg x kg(-1) and midazolam 0.1 mg x kg(-1) but prior to the start of surgery, xenon or nitrous oxide 60% was administered for 15 min. The results showed that xenon caused a minimal decrease in the mean arterial pressure (from 81 (7) to 75 (8) mmHg, mean (SD)), but did not affect the systolic function of the left ventricle, as demonstrated by unchanged left ventricular stroke work index (LVSWI) and the fractional area change of the left ventricle (FAC) derived from transoesophageal echocardiography (TOE). However, in contrast, nitrous oxide was found to decrease the mean arterial pressure (from 81 (8) to 69 (7) mmHg), the LVSWI, and the FAC. The cardiac index, central venous and pulmonary artery occlusion pressures, systemic and pulmonary vascular resistances, and the TOE-derived E/A ratio through the mitral valve were unchanged by xenon or nitrous oxide. We conclude that xenon provides improved haemodynamic stability compared with nitrous oxide, conserving the left ventricular systolic function.
authors.affiliation: Teikyo University, Ichihara Hospital, 3426-3 Anesaki, Ichihara-shi, Chiba-ken, 299-0111, Japan. takigoto@med.teikyo-u.ac.jp
authors.forename: T
authors.initials: T
authors.lastname: Goto
authors.forename: P
authors.initials: P
authors.lastname: Hanne
authors.forename: Y
authors.initials: Y
authors.lastname: Ishiguro
authors.forename: F
authors.initials: F
authors.lastname: Ichinose
authors.forename: Y
authors.initials: Y
authors.lastname: Niimi
authors.forename: S
authors.initials: S
authors.lastname: Morita
mesh_terms: D000368:Aged; D019162:Anesthetics, Combined / Q000494:pharmacology*; D018685:Anesthetics, Inhalation / Q000494:pharmacology*; D018686:Anesthetics, Intravenous / Q000097:blood / Q000494:pharmacology; D002407:Catheterization, Swan-Ganz; D001026:Coronary Artery Bypass; D004311:Double-Blind Method; D017548:Echocardiography, Transesophageal; D005260:Female; D005283:Fentanyl / Q000097:blood / Q000494:pharmacology; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008874:Midazolam / Q000097:blood / Q000494:pharmacology; D008875:Middle Aged; D016343:Monitoring, Intraoperative / Q000379:methods; D009609:Nitrous Oxide / Q000494:pharmacology*; D011446:Prospective Studies; D014978:Xenon / Q000494:pharmacology*
chemical_list: D019162:Anesthetics, Combined; D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D014978:Xenon; D009609:Nitrous Oxide; D008874:Midazolam; D005283:Fentanyl